NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Acumen Pharmaceuticals Inc. Common Stock (NASDAQ: ABOS)

 
ABOS Technical Analysis
5
As on 3rd Jul 2025 ABOS SHARE Price closed @ 1.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.02 & Strong Sell for SHORT-TERM with Stoploss of 3.72 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABOSSHARE Price

Open 1.15 Change Price %
High 1.17 1 Day 0.03 2.65
Low 1.13 1 Week -0.10 -7.94
Close 1.16 1 Month 0.10 9.43
Volume 93674 1 Year -2.47 -68.04
52 Week High 4.64 | 52 Week Low 0.90
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.16 5.37%
HCTI 0.03 50.00%
NVDA 159.34 1.33%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 1.47 5.00%
WINT 0.93 20.78%
BTBT 2.94 11.79%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.22 -77.08%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
ABOS
Daily Charts
ABOS
Intraday Charts
Whats New @
Bazaartrend
ABOS
Free Analysis
 
ABOS Important Levels Intraday
RESISTANCE1.24
RESISTANCE1.21
RESISTANCE1.20
RESISTANCE1.18
SUPPORT1.14
SUPPORT1.12
SUPPORT1.11
SUPPORT1.08
 
ABOS Forecast July 2025
4th UP Forecast4.13
3rd UP Forecast3.18
2nd UP Forecast2.59
1st UP Forecast2
1st DOWN Forecast0.32
2nd DOWN Forecast-0.27
3rd DOWN Forecast-0.86
4th DOWN Forecast-1.81
 
ABOS Weekly Forecast
4th UP Forecast2.14
3rd UP Forecast1.83
2nd UP Forecast1.63
1st UP Forecast1.44
1st DOWN Forecast0.88
2nd DOWN Forecast0.69
3rd DOWN Forecast0.49
4th DOWN Forecast0.18
 
ABOS Forecast2025
4th UP Forecast9.31
3rd UP Forecast6.7
2nd UP Forecast5.08
1st UP Forecast3.47
1st DOWN Forecast-1.15
2nd DOWN Forecast-2.76
3rd DOWN Forecast-4.38
4th DOWN Forecast-6.99
 
 
ABOS Other Details
Segment EQ
Market Capital 568576832.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABOS Address
ABOS
 
ABOS Latest News
 
Your Comments and Response on Acumen Pharmaceuticals Inc. Common Stock
 
ABOS Business Profile
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia. Address: 427 Park St., Charlottesville, VA, United States, 22902
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service